Compare MO SJR 27 (2025) and MO SJR 33 (2025)

The introduced text of these two bills, side by side, with the wording they share.

285 shared 8-word phrases found in the introduced text of these two bills.

This highlights wording the two bills share in their introduced text. A shared passage may include text that both bills quote from the same existing law, not only language either one drafted. A match shows that the texts overlap; it does not show who drafted a bill, and filing order alone does not show which bill copied which.

MO SJR 27 (2025)MO SJR 33 (2025)
FIRST REGULAR SESSION SENATE JOINT RESOLUTION NO. 27 103RD GENERAL ASSEMBLY INTRODUCED BY SENATOR CARTER. 1007S.02I KRISTINA MARTIN, Secretary JOINT RESOLUTION Submitting to the qualified voters of Missouri, an amendment to article I of the Constitution of Missouri, by adding thereto one new section relating to reproductive health care. Be it resolved by the Senate, the House of Representatives concurring therein: That at the next general election to be held in the 1 state of Missouri, on Tuesday next following the first Monday 2 in November, 2026, or at a special election to be called by 3 the governor for that purpose, there is hereby submitted to 4 the qualified voters of this state, for…FIRST REGULAR SESSION SENATE JOINT RESOLUTION NO. 33 103RD GENERAL ASSEMBLY INTRODUCED BY SENATOR SCHNELTING. 0897S.03I KRISTINA MARTIN, Secretary JOINT RESOLUTION Submitting to the qualified voters of Missouri, an amendment to article I of the Constitution of Missouri, by adding thereto one new section relating to reproductive health care. Be it resolved by the Senate, the House of Representatives concurring therein: That at the next general election to be held in the 1 state of Missouri, on Tuesday next following the first Monday 2 in November, 2026, or at a special election to be called by 3 the governor for that purpose, there is hereby submitted to 4 the qualified voters of this state,…
for the purpose of gender transition 7 to children under eighteen years of age. The provisions of 8 this section shall not apply to the use of such surgeries, 9 drugs, or hormones to treat children born with a medically 10 verifiable disorder of sex development or to treat any 11 SJR 27 2 infection, injury, disease, or disorder unrelated to the 12 purpose of a gender transitionfor the purpose of 19 gender transition to children under eighteen years of age. 20 The provisions of this section shall not apply to the use of 21 such surgeries, drugs, or hormones to treat children born 22 with a medically verifiable disorder of sex development or 23 to treat any infection, injury, disease, or disorder 24 unrelated to the purpose of a gender transition
As used in this section, the following terms shall 14 mean: 15 (1) "Cross-sex hormones", testosterone, estrogen, or 16 other androgens given to an individual in amounts that are 17 greater or more potent than would normally occur naturally 18 in a healthy individual of the same age and sex; 19 (2) "Gender transition surgery", a surgical procedure 20 performed for the purpose of assisting an individualAs used in this section, the following terms mean: 39 (1) "Cross-sex hormones", testosterone, estrogen, or 40 other androgens given to an individual in amounts that are 41 SJR 33 3 greater or more potent than would normally occur naturally 42 in a healthy individual of the same age and sex; 43 (2) "Gender transition surgery", a surgical procedure 44 performed for the purpose of assisting an individual
as a gender different from his or her 22 biological sexas a gender different from his 46 or her biological sex
Puberty-blocking drugs", gonadotropin-releasing 24 hormone analogues or other synthetic drugs used to stop 25 luteinizing hormone secretion and follicle stimulating 26 hormone secretion, synthetic antiandrogen drugs to block the 27 androgen receptor, or any other drug used to delay or 28 suppress pubertal development in children for the purpose of 29 assisting an individual with a gender transitionPuberty-blocking drugs", gonadotropin-releasing 58 hormone analogues or other synthetic drugs used to stop 59 luteinizing hormone secretion and follicle stimulating 60 hormone secretion, synthetic antiandrogen drugs to block the 61 androgen receptor, or any other drug used to delay or 62 suppress pubertal development in children for the purpose of 63 assisting an individual with a gender transition